AKT1 Recombinant Rabbit Monoclonal Antibody [ST05-09]
Overview
Product Name
AKT1 Recombinant Rabbit Monoclonal Antibody [ST05-09]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within C-terminal human AKT1.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IHC-P, IP, FC, IHC-Fr, IF-Cell
Molecular Weight
Predicted band size: 56 kDa
Positive Control
HeLa cell lysate, A549 cell lysate, C6 cell lysate, PC-12 cell lysate, SH-SY5Y cell lysates, mouse brain tissue, mouse kidney tissue, human kidney tissue, mouse prostate tissue, Hela, mouse hippocampus tissue, mouse cerebral cortex tissue, MCF7, C6.
Conjugation
unconjugated
Clone Number
ST05-09
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000-1:10,000
-
IHC-P
-
1:2,000-1:5,000
-
FC
-
1:1,000
-
IP
-
1-2μg/sample
-
IHC-Fr
-
1:200
-
IF-Cell
-
1:100
Target
Function
The serine/threonine kinase Akt family contains several members, including Akt1 (also designated PKB or RacPK), Akt2 (also designated PKBβor RacPK-β) and Akt 3 (also designated PKB? or thyoma viral proto-oncogene 3), which exhibit sequence homology with the protein kinase A and C families and are encoded by the c-Akt proto-oncogene. All members of the Akt family have a pleckstrin homology domain. Akt1 and Akt2 are activated by PDGF stimulation. This activation is dependent on PDGFR-β tyrosine residues 740 and 751, which bind the subunit of the phosphatidylinositol 3-kinase (PI 3-kinase) complex. Activation of Akt1 by insulin or insulin-growth factor-1(IGF-1) results in phosphorylation of both Thr 308 and Ser 473. Phosphorylation of both residues is important to generate a high level of Akt1 activity, and the phosphorylation of Thr 308 is not dependent on phosphorylation of Ser 473 in vivo. Thus, Akt proteins become phosphorylated and activated in insulin/IGF-1-stimulated cells by an upstream kinase(s). The activation of Akt1 and Akt2 is inhibited by the PI kinase inhibitor wortmannin, suggesting that the protein signals downstream of the PI kinases.
Background References
1. Wang, H. et al. 2016. CSL regulates AKT to mediate androgen independence in prostate cancer progression. Prostate. 76: 140-50.
2. Wang, Z. et al. 2016. Protein 41N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC. Oncotarget. 7: 509-23.
Sequence Similarity
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.
Tissue Specificity
Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages.
Post-translational Modification
O-GlcNAcylation at Thr-305 and Thr-312 inhibits activating phosphorylation at Thr-308 via disrupting the interaction between AKT1 and PDPK1. O-GlcNAcylation at Ser-473 also probably interferes with phosphorylation at this site.; Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308 and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1. Phosphorylated at Thr-308 and Ser-473 by IKBKE and TBK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells. Ser-473 phosphorylation is enhanced by signaling through activated FLT3 (By similarity). Ser-473 is dephosphorylated by PHLPP. Dephosphorylated at Thr-308 and Ser-473 by PP2A phosphatase. The phosphorylated form of PPP2R5B is required for bridging AKT1 with PP2A phosphatase. Ser-473 is dephosphorylated by CPPED1, leading to termination of signaling.; Ubiquitinated via 'Lys-48'-linked polyubiquitination by ZNRF1, leading to its degradation by the proteasome (By similarity). Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. Also ubiquitinated by TRIM13 leading to its proteasomal degradation. Phosphorylated, undergoes 'Lys-48'-linked polyubiquitination preferentially at Lys-284 catalyzed by MUL1, leading to its proteasomal degradation.; Acetylated on Lys-14 and Lys-20 by the histone acetyltransferases EP300 and KAT2B. Acetylation results in reduced phosphorylation and inhibition of activity. Deacetylated at Lys-14 and Lys-20 by SIRT1. SIRT1-mediated deacetylation relieves the inhibition.
Subcellular Location
Cell membrane, Cytoplasm, Membrane, Nucleus.
Synonyms
AKT 1 antibody
AKT antibody
AKT1 antibody
AKT1_HUMAN antibody
MGC99656 antibody
PKB antibody
PKB-ALPHA antibody
PRKBA antibody
Protein Kinase B Alpha antibody
Protein kinase B antibody
ExpandAKT 1 antibody
AKT antibody
AKT1 antibody
AKT1_HUMAN antibody
MGC99656 antibody
PKB antibody
PKB-ALPHA antibody
PRKBA antibody
Protein Kinase B Alpha antibody
Protein kinase B antibody
Proto-oncogene c-Akt antibody
RAC Alpha antibody
RAC antibody
RAC-alpha serine/threonine-protein kinase antibody
RAC-PK-alpha antibody
CollapseImages
-
☑ Knockdown (KD)
Western blot analysis of AKT1 on different lysates with Rabbit anti-AKT1 antibody (ET1609-47) at 1/5,000 dilution.
Lane 1: A549-si NT cell lysate
Lane 2: A549-si AKT1 cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 56 kDa
Observed band size: 56 kDa
Exposure time: 40 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-47) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of AKT1 on different lysates with Rabbit anti-AKT1 antibody (ET1609-47) at 1/5,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: A549 cell lysate
Lane 3: C6 cell lysate
Lane 4: PC-12 cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 56 kDa
Observed band size: 56 kDa
Exposure time: 43 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-47) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of AKT1 on SH-SY5Y cell lysates with Rabbit anti-AKT1 antibody (ET1609-47) at 1/5,000 dilution.
Lysates/proteins at 10 µg/Lane.
Predicted band size: 56 kDa
Observed band size: 56 kDa
Exposure time: 2 minutes;
10% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-47) at 1/5,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at /50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded mouse brain tissue with Rabbit anti-AKT1 antibody (ET1609-47) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-47) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Rabbit anti-AKT1 antibody (ET1609-47) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-47) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Application: IHC-Fr
Species: Mouse
Site: Hippocampus
Sample: Frozen section
Antibody concentration: 1/200
Antigen retrieval: The section was pre-treated using 1% SDS buffer (in PBS, pH 7.4) for 5 minutes at room temperature. -
Application: IHC-Fr
Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1/200
Antigen retrieval: The section was pre-treated using 1% SDS buffer (in PBS, pH 7.4) for 5 minutes at room temperature. -
Immunocytochemistry analysis of MCF7 cells labeling AKT1 with Rabbit anti-AKT1 antibody (ET1609-47) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-AKT1 antibody (ET1609-47) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling AKT1 with Rabbit anti-AKT1 antibody (ET1609-47) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-AKT1 antibody (ET1609-47) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of MCF7 cells labeling AKT1.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1609-47, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
AKT1 was immunoprecipitated from 0.2 mg MCF7 cell lysate with ET1609-47 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1609-47 at 1/1,000 dilution. Anti-Rabbit IgG for IP Nano-secondary antibody (NBI01H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: MCF7 cell lysate (input)
Lane 2: ET1609-47 IP in MCF7 cell lysate
Lane 3: Rabbit IgG instead of ET1609-47 in MCF7 cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 23 seconds; ECL: K1801
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
FAM83D facilitates EMT and metastasis of cervical cancer via interaction with GSK3β and inactivation of GSK3β/stabilization of Snail signaling
Journal: Biology Direct
DOI: 10.1186/s13062-026-00761-z
IF: 4.9
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Journal: Cancer Research
DOI: 10.1158/0008-5472.CAN-24-4916
IF: 16.6
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Effects of Dietary Peptides From Essence of Chicken on Neuroinflammation and Their Synergism in Neuroprotection
Journal: International Journal for Vitamin and Nutrition Research
DOI: 10.31083/IJVNR45261
IF: 2.5
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
Hawthorn fruit extracts alleviate high-fat diet-induced NAFLD by inhibiting ERK and regulating hepatic purine metabolism
Journal: Food & Function
DOI: 10.1039/D5FO03640B
IF: 5.4
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2025.1614702
IF: 5.9
Application: WB
Reactivity: Human
Publish date: 2025 Sept
-
Swietenine improved the progression of diabetic nephropathy through inhibiting ferroptosis via activating Akt/GSK-3β/Nrf2 signaling pathway
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.119981
IF: 4.8
Application: WB
Reactivity: Rat
Publish date: 2025 May
-
Resveratrol Promotes Wound Healing by Enhancing Angiogenesis via Inhibition of Ferroptosis
Journal: Food Science & Nutrition
DOI: 10.1002/fsn3.70254
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth
Journal: Cell Reports
DOI: 10.1016/j.celrep.2025.115441
IF: 7.5
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Therapeutic Effects and Mechanisms of Alcohol Extracts from Polygala fallax Hemsl on Endometriosis in Rats
Journal: Archives Of Biochemistry And Biophysics
DOI: 10.1016/j.abb.2025.110393
IF: 3.8
Application: WB
Reactivity: Rat
Publish date: 2025 Mar
-
PRDX6 Drives Breast Cancer Progression Through Mitochondrial Biosynthesis and Oxidative Phosphorylation
Journal: Cancer Medicine
DOI: 10.1002/cam4.71005
IF: 3.1
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Vitamin D against diabetic adipose tissue inflammation through SHP-1/STAT3 pathway
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115131
IF: 4.7
Application:
Reactivity:
Publish date: 2025 Jun
-
Multifunctional nanomedicine targeting the 'seed-and-soil' of hair follicles via simultaneous alleviation of oxidative stress and activation of autophagy for androgenetic alopecia therapy
Journal: Materials Today Bio
DOI: 10.1016/j.mtbio.2025.102145
IF: 10.2
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Investigating the protective role of Astragalus polysaccharides against fluoride-induced testicular injury via network pharmacology, molecular docking, and in vivo experiments
Journal: Reproductive Toxicology
DOI: 10.1016/j.reprotox.2025.109012
IF: 2.8
Application: IHC
Reactivity: Rat
Publish date: 2025 Jul
-
The Mechanosensitive Ion Channel Piezo1 Regulates Chondrocyte Homeostasis Through the PI3K/AKT/mTORC1 Pathway in Osteoarthritis
Journal: Journal Of Cellular And Molecular Medicine
DOI: 10.1111/jcmm.70734
IF: 4.2
Application: WB
Reactivity: Rat
Publish date: 2025 Jul
-
Activation of the WNT4/ β-catenin/FOXO1 pathway by PDK1 promotes cervical cancer metastasis and EMT process
Journal: Journal Of Molecular Histology
DOI:
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Activation of the WNT4/ β-catenin/FOXO1 pathway by PDK1 promotes cervical cancer metastasis and EMT process
Journal: JOURNAL OF MOLECULAR HISTOLOGY
DOI: 10.1007/s10735-024-10342-x
IF: 2.2
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Toosendanin Induces Cell Cycle Arrest and Apoptosis to Suppress Diffuse Large B-Cell Lymphoma Growth by Inhibiting PI3Kα/β and PLK1 Signaling
Journal: Phytotherapy Research
DOI: 10.1002/ptr.8439
IF: 6.1
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Flavonoid-Rich Extract from Bombyx batryticatus Alleviate LPS-Induced Acute Lung Injury via the PI3K/MAPK/NF-κB Pathway
Journal: International Journal Of Molecular Sciences
DOI: 10.3390/ijms262412057
IF: 4.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
LRRC1 Promotes Angiogenesis Through Regulating AKT/GSK3β/β-Catenin/VEGFA Signaling Pathway in Hepatocellular Carcinoma
Journal: Cells
DOI: 10.3390/cells14231919
IF: 5.2
Application: WB
Reactivity: Human
Publish date: 2025 Dec
-
Chidamide and anlotinib synergistically inhibit high grade B-cell lymphomas via PI3K/AKT signaling pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-025-10334-1
IF: 3.9
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Aug
-
The ultrafine powder of atractylodis macrocephalae rhizoma improves immune function in naturally aging rats by regulating the PI3K/Akt/NF-κB signaling pathway
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2025.1550357
IF: 4.4
Application: WB
Reactivity: Rat
Publish date: 2025 Apr
-
DL-3-n-butylphthalide inhibits astrocyte activation in the cortical penumbra of ischemia-reperfusion model rats via AKT signaling
Journal: Brain Research Bulletin
DOI: 10.1016/j.brainresbull.2025.111332
IF: 3.5
Application: WB
Reactivity: Rat
Publish date: 2025 Apr
-
AKT1 as a therapeutic target for platinum-resistant SOX2 positive ovarian cancer cells
Journal: Scientific Reports
DOI: 10.1038/s41598-025-92036-2
IF: 3.8
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Utilizing bioinformatics to identify biomarkers and analyze their expression in relation to immune cell ratios in femoral head necrosis
Journal: Frontiers In Physiology
DOI: 10.3389/fphys.2025.1373721
IF: 3.2
Application: IHC-P
Reactivity: Human
Publish date: 2025 Apr
-
Mechanistic Insights into the Anti-Glioma Effects of Exosome-Like Nanoparticles Derived from Garcinia Mangostana L.: A Metabolomics, Network Pharmacology, and Experimental Study
Journal: International Journal Of Nanomedicine
DOI: 10.2147/IJN.S514930
IF: 6.6
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
Network pharmacology and phytochemical composition combined with validation in vivo and in vitro reveal the mechanism of platycodonis radix ameliorating PM2.5-induced acute lung injury
Journal: Journal Of Ethnopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Sep
-
Dietary oxygenated water mitigates type 2 diabetes mellitus by modulating gut microbiota and enhancing glucose metabolism in skeletal muscle
Journal: Food Bioscience
DOI:
IF: 4.8
Application: WB
Reactivity: Rabbit
Publish date: 2024 Sep
-
Neurons enhance blood–brain barrier function via upregulating claudin-5 and VE-cadherin expression due to glial cell line-derived neurotrophic factor secretion
Journal: eLife
DOI: 10.7554/eLife.96161
IF: 6.4
Application: WB
Reactivity: Mouse
Publish date: 2024 Oct
-
Schisandrin A alleviates non-alcoholic fatty liver disease by improving liver metabolic disorders and suppressing the GSK3β signaling pathway
Journal: Food Bioscience
DOI:
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Oct
-
Role of HDAC3 in the epithelial-mesenchymal transition of retinal pigment epithelium cells: implications for proliferative vitreoretinopathy
Journal: Heliyon
DOI:
IF: 3.4
Application: IP
Reactivity: Mouse
Publish date: 2024 Oct
-
Microenvironment-responsive injectable hydrogel for neuro-vascularized bone regeneration
Journal: Materials Today Bio
DOI:
IF:
Application: WB
Reactivity: Rat
Publish date: 2024 Nov
-
Aberrant methylation and expression of TNXB promote chondrocyte apoptosis and extracullar matrix degradation in hemophilic arthropathy via AKT signaling
Journal: eLife
DOI: 10.7554/eLife.93087
IF: 6.4
Application: WB
Reactivity: Human
Publish date: 2024 May
-
Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia-related chronic kidney disease
Journal: Medicine And Communication
DOI: 10.1002/mco2.580
IF: 10.7
Application: WB
Reactivity: Mouse
Publish date: 2024 Jun
-
IL-17A regulates collagen synthesis after autophagy in bronchial fibroblasts through the PI3K/AKT/mTOR pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: WB
Reactivity: Rat
Publish date: 2024 Jan
-
Screening and bioinformatics analysis of a potential ceRNA network in melatonin-induced cashmere growth in Liaoning cashmere goats
Journal: Original Study
DOI:
IF:
Application: WB
Reactivity: Goat
Publish date: 2024 Feb
-
A Multifunctional miRNA Delivery System Based on Tetrahedral Framework Nucleic Acids for Regulating Inflammatory Periodontal Ligament Stem Cells and Attenuating Periodontitis Bone Loss
Journal: ACS Applied Materials & Interfaces
DOI:
IF: 8.3
Application: WB
Reactivity: Rat
Publish date: 2024 Dec
-
Luteolin-mediated phosphoproteomic changes in chicken splenic lymphocytes: unraveling the detoxification mechanisms against ammonia-induced stress
Journal: Journal Of Hazardous Materials
DOI:
IF: 12.2
Application: WB
Reactivity: Rat
Publish date: 2024 Dec
-
Dipeptide PA3264 derived from rare and endangered Squama Manis is a novel bioactive peptide for the treatment of triple-negative breast cancer
Journal: Chinese Medicine
DOI:
IF: 5.3
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
Rational formulation of saponin and dexamethasone for the synergistic treatment of rheumatoid arthritis in vivo
Journal: Applied Materials Today
DOI:
IF: 7.2
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma
Journal: Cell Communication And Signaling
DOI:
IF: 8.4
Application: WB
Reactivity: Human,Mouse
Publish date: 2024 Apr
-
Integrated analyses for identification of a three-gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment
Journal: Journal Of Cellular And Molecular Medicine
DOI: 10.1111/jcmm.18211
IF: 4.3
Application: WB
Reactivity: Human
Publish date: 2024 Apr
-
Evodiamine Inhibits the Progression of Esophageal Aquamous Cell Carcinoma via Modulating PI3K/AKT/mTOR Pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI: 10.21203/rs.3.rs-4133300/v1
IF:
Application: WB
Reactivity: Human,Mouse
Publish date: 2024 Apr
-
TRIM28 recruits E2F1 to regulate CBX8-mediated cell proliferation and tumor metastasis of ovarian cancer
Journal: Human Cell
DOI: 10.1007/s13577-023-00983-7
IF: 4.3
Application: WB
Reactivity: Human
Publish date: 2023 Sept
-
Apatinib Inhibits Bladder Cancer through Suppression of the VEGFR2-PI3K-AKT Signaling Pathway as Revealed by Network Pharmacology and in vitro Experimental Verification
Journal: Combinatorial Chemistry & High Throughput Screening
DOI:
IF: 1.8
Application: WB
Reactivity: Human
Publish date: 2023 Mar
-
Multifunctional gold nanorods in low-temperature photothermal interactions for combined tumor starvation and RNA interference therapy
Journal: Acta Biomaterialia
DOI:
IF: 10.633
Application: WB
Reactivity: Mouse
Publish date: 2023 Mar
-
The mechanism of action of paeoniae radix rubra-angelicae sinensis radix drug pair in the treatment of rheumatoid arthritis through PI3K/AKT/NF-κB signaling pathway
Journal: Frontiers In Pharmacology
DOI:
IF: 5.988
Application: WB
Reactivity: Rat
Publish date: 2023 Mar
-
RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization
Journal: Scientific Reports
DOI: 10.1038/s41598-023-48801-2
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2023 Dec
-
Homoharringtonine induces apoptosis of mammary carcinoma cells by inhibiting the AKT/mTOR signaling pathway
Journal: Veterinary And Comparative Oncology
DOI: 10.1111/vco.12948
IF: 2.1
Application: WB
Reactivity: Dog
Publish date: 2023 Dec
-
Cucurbitacin E reduces IL-1β-induced inflammation and cartilage degeneration by inhibiting the PI3K/Akt pathway in osteoarthritic chondrocytes
Journal: Journal Of Translational Medicine
DOI: 10.1186/s12967-023-04771-7
IF: 7.4
Application: WB
Reactivity: Human
Publish date: 2023 Dec
-
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
Journal: Cell Discovery
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling
Journal: Cell Discovery
DOI:
IF: 33.5
Application: WB
Reactivity: Mouse
Publish date: 2023 Aug
-
A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages
Journal: Nanoscale
DOI:
IF: 7.790
Application: WB
Reactivity: Mouse
Publish date: 2022 Mar
-
Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes
Journal: Cell Discovery
DOI:
IF: 38.079
Application: WB
Reactivity: Mouse
Publish date: 2022 Jun
-
PBRM1 deficiency oncogenic addiction is associated with activated AKT–mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells
Journal: Journal Of Cellular And Molecular Medicine
DOI:
IF: 5.295
Application: WB
Reactivity: Human
Publish date: 2022 Jul
-
Streptococcus pneumoniae promotes migration and invasion of A549 cells in vitro by activating mTORC2/AKT through up-regulation of DDIT4 expression
Journal: Frontiers In Microbiology
DOI:
IF: 6.064
Application: WB
Reactivity: Human
Publish date: 2022 Dec
-
β2-Adrenergic Receptor Enhances the Alternatively Activated Macrophages and Promotes Biliary Injuries Caused by Helminth Infection
Journal: Frontiers In Immunology
DOI:
IF: 7.562
Application: WB
Reactivity: Mouse
Publish date: 2021 Oct
-
<html><html><html>Mettl14-Mediated m<sup>6</sup>A Modification Facilitates Liver Regeneration by Maintaining Endoplasmic Reticulum Homeostasis. Cellular and molecular gastroenterology and hepatology, S2352-345X(21)00072-2. Advance online publication.</html></html></html>
Journal: Cellular And Molecular Gastroenterology And Hepatology
DOI:
IF: 7.076
Application: WB
Reactivity: Mouse
Publish date: 2021 Apr
-
miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1. BMC cancer, 20(1), 1028.
Journal: BMC Cancer
DOI:
IF: 3.153
Application: WB
Reactivity: Human
Publish date: 2020 Oct
-
Network pharmacology-based identification of the antitumor effects of taraxasterol in gastric cancer
Journal: International Journal Of Immunopathology And Pharmacology
DOI:
IF: 2.209
Application: IHC-P
Reactivity: Mouse
Publish date: 2020 Jul
-
Combination of HSP90 and autophagy inhibitors promotes hepatocellular carcinoma apoptosis following incomplete thermal ablation
Journal: Molecular Medicine Reports
DOI:
IF: 1.851
Application: WB
Reactivity: Mouse
Publish date: 2020 Jul
-
Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
Journal: Cell Death & Disease
DOI:
IF: 5.64
Application: WB
Reactivity: Human
Publish date: 2019 Feb
-
Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway.
Journal: In Vitro Cellular & Developmental Biology - Animal
DOI:
IF: 1.645
Application: WB
Reactivity: Rat
Publish date: 2019 Dec
-
Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis. Cellular oncology (Dordrecht), 42(4), 537–554.
Journal: Cellular Oncology
DOI:
IF: 5.02
Application: WB,Co-IP,IHC-P
Reactivity: Human
Publish date: 2019 Aug
Products with the same target and pathway
Phospho-AKT1 (T450) Recombinant Rabbit Monoclonal Antibody [SD08-12]
Application: WB,IHC-P,IP,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
AKT1 Recombinant Rabbit Monoclonal Antibody [PSH0-50]
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse,Rat,Green monkey
Conjugate: unconjugated
Phospho-AKT1 (S124) Recombinant Rabbit Monoclonal Antibody [JJ08-46]
Application: WB,IF-Cell,IHC-P,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
AKT1 Recombinant Rabbit Monoclonal Antibody [PSH0-50] - BSA and Azide free
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse,Rat,Green monkey
Conjugate: unconjugated
AKT1 Recombinant Rabbit Monoclonal Antibody [ST05-09] - BSA and Azide free
Application: WB,IHC-P,IP,FC,IHC-Fr,IF-Cell
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
AKT1 Mouse Monoclonal Antibody [D9-9-C9]
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Phospho-AKT1 (S129) Recombinant Rabbit Monoclonal Antibody [JE59-50]
Application: WB
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated